1 |
Deng F, Tao F, Xu Z, Zhou J, Gong X, Zhang R, Huang T. Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes. Computational and Mathematical Methods in Medicine 2022;2022:1-20. [DOI: 10.1155/2022/7116080] [Reference Citation Analysis]
|
2 |
Ye Y, Jiang H, Wu Y, Wang G, Huang Y, Sun W, Zhang M. Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis. Front Mol Biosci 2022;9:1001225. [DOI: 10.3389/fmolb.2022.1001225] [Reference Citation Analysis]
|
3 |
Aamna B, Kumar Dan A, Sahu R, Behera SK, Parida S. Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell cycle and metastasis. J Cell Physiol 2022. [PMID: 35908197 DOI: 10.1002/jcp.30847] [Reference Citation Analysis]
|
4 |
Li W, Liu Z, Liu Y, Qian L, Zhang Z, Nie L, Qu X. Antigallbladder Carcinoma Activity Analysis of a New Nanometer Drug Delivery System Based on Data Acquisition. Contrast Media Mol Imaging 2022;2022:9538051. [PMID: 35854774 DOI: 10.1155/2022/9538051] [Reference Citation Analysis]
|
5 |
Wang L, Yang M, Jin H. PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer. Mol Med Rep 2021;24:613. [PMID: 34184087 DOI: 10.3892/mmr.2021.12252] [Reference Citation Analysis]
|
6 |
Wang L, Yang M, Jin H. PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer. Mol Med Rep 2021;24:613. [PMID: 34184087 DOI: 10.3892/mmr.2021.12252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Wang L, Yang M, Jin H. PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer. Mol Med Rep 2021;24:613. [DOI: 10.3892/mmr.2021.12252] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|